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Abstract
Papillary thyroid carcinoma (PTC) composed by predominant solid areas is diagnosed as a distinct
variant on histological samples. Here we present a case of PTC recognized preoperatively by fine
needle cytology as a solid variant. This diagnosis was made by combining cytology with the
detection of the BRAFVK600-1E mutation, the molecular hallmark of the solid variant of PTC.
Histological and molecular evaluation of the surgical specimen confirmed this pre-operative
diagnosis. Thus combining cytology to BRAF molecular analysis is useful to refine the cytological
diagnosis of this variant also on FNC specimens.
Introduction
The solid variant of papillary thyroid carcinoma (PTC) is
dominated by solid sheets of tumour cells showing typical
nuclear features [1]. Since this sub-type of PTC is a rare
and poorly characterized, there is disagreement on its
behaviour [2]. An aggressive course may be suggested by
its association to vascular invasion and extra-thyroidal
extension in about one-third of cases [1]. Nikiforov et al
showed a slightly higher frequency of distant metastases
and less favourable prognosis than classical PTC [2]. Thus,
the pre-operative sub-typing of PTC may help in refining
the appropriate therapeutic strategy and in leading to a
more aggressive surgery.
Molecular tests are increasingly being applied to thyroid
fine needle cytology (FNC) samples as additional diag-
nostic tools [3]. In particular, mutations of the BRAF
kinase gene are highly prevalent and specific for PTC [4].
Thus, their detection is very useful to refine the pre-oper-
ative diagnosis of PTC in those cases that are indetermi-
nate on FNCs [5-10]. In addition, analysis of a large series
of histological samples of PTC has shown a close relation-
ship between PTC typing and some BRAF  mutations,
which can be exploited to specify the variant of PTC pre-
operatively [11]. In fact the most frequent BRAF mutation,
the V600E amino acid change, is associated to a papillary
pattern of growth in both conventional and variant (tall
cell, Warthin-like and oncocytic) PTCs, whereas the much
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less frequent K601E mutation has only been observed in
the follicular variant of PTC [11]. In addition, a triplet
deletion of the BRAF gene leading to the replacement of a
valine and a lysine by a glutamate (BRAF V600E + K601),
has been associated only to the solid variant of PTC on
histological samples by Trovisco et al [12]. This latter rela-
tionship has been confirmed in a recent investigation by
Lupi et al; this latter study also showed the very low fre-
quency of this event, that occurred in one case out of 500
PTCs histologically examined [13]. The association
between the BRAF V600E + K601 and PTC solid variant is
further confirmed by this present case; the interest relies
on the fact that the correct diagnosis of solid variant of
PTC was made preoperatively by combining the cytologi-
cal evaluation to the molecular detection of the BRAF
V600E + K601 mutation on FNC samples.
Case presentation
A 64 year old man presenting with a 17 mm single solid
nodule of the right thyroid lobe underwent fine needle
biopsy under ultrasound guidance. Two smears prepared
for standard cytological assessment were Diff-Quick®
stained and evaluated on-site. The immediate microscopic
observation of highly cellular smears prompted the per-
formance of an additional pass; the obtained material was
suspended in 300 μl of RNAlater® (QIAGEN Inc.) for
molecular analysis of the BRAF mutational status.
The smears showed, in a clean background with only a lit-
tle amount of thick colloid, an elevated cellularity com-
posed by neoplastic epithelial follicular cells prevalently
arranged in syncytial-type tissue fragments (Figure 1); the
cells present at the periphery of these groups often showed
overlapping and crowding (Figure 2). Less frequently the
epithelial follicular cells were organized in monolayered
sheets; the cells in these groups showed a certain degree of
variability in cellular shape and size with anisocytosis and
anisonucleosis (Figure 3). The nuclear changes included
grooves and micronucleoli, whereas intranuclear inclu-
sions were not observed. Since these cytological features
were not fully diagnostic but only suspicious for PTC, the
molecular analysis of the aspirated material was consid-
ered useful to refine the cytological diagnosis.
FNC sample of a solid variant of PTC Figure 3
FNC sample of a solid variant of PTC. At higher magnification 
note the presence of enlarged nuclei with fine chromatin, 
with occasional nuclear grooves and micronucleoli. These 
changes prompted the performance of a second pass to per-
form BRAF molecular analysis. (Diff-Quick® staining 40×)
FNC sample of a solid variant of PTC Figure 1
FNC sample of a solid variant of PTC. At low power, in a 
clean background solid aggregates of epithelial follicular cells 
arranged in syncytial-type tissue fragments are observed 
(Diff-Quick® staining 4×)
FNC sample of a solid variant of PTC Figure 2
FNC sample of a solid variant of PTC. Microscopic field con-
taining monolayered epithelial cellular sheets. Note the 
occurrence of nuclar overlapping and crowding and also of a 
certain degree of variability in cellular shape and size with 
anisocytosis and anisonucleosis. (Diff-Quick® staining 10×)CytoJournal 2008, 5:2 http://www.cytojournal.com/content/5/1/2
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For the analysis of BRAF mutational status DNA was puri-
fied from the thyroid cells suspended in RNAlater by using
the QIAAMP DNA Mini Kit following the manufacturer's
instructions (QIAGEN Inc). The complete coding
sequence of exon 15 of BRAF was amplified by polymer-
ase chain reaction; primers sequence: BRAF exon 15 [for-
ward]: 5'-CTCATCCTAACACATTTCAAGCC-3'; BRAF
exon 15 [reverse]: 5'-CTATAGTTGAGACCTTCAAT-
GACTTTC-3'). Appropriate positive (DNA from the neo-
plastic FRO cell line) and negative controls were included.
The PCR product underwent elctrophoresis in agarose gel
at the 100 V for 30 minutes (Fig. 4A) and it was analyzed
for mutation by direct sequencing with a prior enzymatic
purifying treatment and subsequent automatic Sanger
sequencing on both strands. A triplet deletion of the cod-
ing nucleotides 1799 to 1801 (TGA 1799–1801 deletion)
was detected (Fig. 4B). On the basis of the cytological
findings and of the molecular results, and in considera-
tion of the reported strong association between the TGA
1799–1801 deletion and the solid variant of PTC, the pre-
operative diagnosis was refined and a total thyroidectomy
was recommended.
Molecular analysis of BRAF mutational status on matched cyto-histological samples Figure 4
Molecular analysis of BRAF mutational status on matched cyto-histological samples. Electrophoresys of the PCR product of 
BRAF exon (A). Sequencing profile/fluorograph of the matched cytological (B) and histological (C) samples with the respective 
nucleotide (Nt) sequences of WT (1 BRAFWT) and mutated (2 BRAFVK600-1E) alleles. The box red in wild-type sequence shows 
the deleted nucleotide triplet TGA 1799 – 1801.CytoJournal 2008, 5:2 http://www.cytojournal.com/content/5/1/2
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Macroscopic examination of the resected specimen
showed in the right lobe a 19 mm, well-delimited, non
encapsulated lesion, nearly exclusively composed by solid
sheets of tumour cells with typical nuclear features of pap-
illary carcinoma (Fig. 5). Nuclear pleomorphism and
tumour cell necrosis were not observed; the histological
diagnosis of solid variant of papillary thyroid carcinoma
was made (Fig. 6). DNA was purified from tumour paraf-
fin embedded block by using the QIAAMP DNA Mini Kit
(QIAGEN Inc.) and the same molecular analysis above
described for the cytological sample was applied; the TGA
1799–1801 deletion was detected also on the matched
histological specimen (Fig. 4C).
Conclusion
Modern cytology can exploit reliable molecular markers
to refine the microscopic diagnosis. In the present study
we report a combined cytological and molecular diagno-
sis of solid variant of papillary thyroid carcinoma. The
cytology alone was not conclusive; the little amount of
colloid, the elevated cellularity raised the suspect of a neo-
plasm; however only a slight degree of nuclear changes
were observed: grooves and micronucleoli were sporadic,
whereas intranuclear inclusions were not observed. The
on-site evaluation of the Diff-Quick stained smear was
very useful to specify the need of an additional pass to
obtain material for BRAF molecular analysis. This is an
ideal marker in thyroid cytology since it is highly specific
for PTC [4]. Furthermore the close relationship between
the type of BRAF mutation and the histological type of
PTC was useful to predict on cytological samples the final
precise diagnosis. The BRAF  triplet deletion TGA
1799–1801 is the hallmark of the solid variant of PTC,
having been reported only in this variant [12,13]. Here we
first report the detection of this molecular abnormality on
FNC samples and we conclude that the BRAF triplet detec-
tion is of value as a predictive marker of solid variant on
subsequently resected PTC.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
GT conceived the study and wrote the manuscript; RM
and UM carried out the molecular study; IC evaluated the
cytological sample; AF evaluated the results; MA evaluated
the histological sample; LP participated in the design of
the study. All authors read and approved the final manu-
script.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Acknowledgements
This study was funded by the Regione Campania grant to LP "Nuovi mar-
catori molecolari nella diagnosi citologica del nodulo tiroideo". We thank 
Dr. Domenico Vitale (CEINGE Sequencing Facility) for gene sequencing.
References
1. World Health Organization Classification of Tumours.
Tumours of Endocrine Organs.  Edited by: De Lellis RA, Lloyd
RV, Heitz PU, Eng C. Lyon: Chapman and Hall; 1993:57-66. 
2. Nikiforov YE, Erickson LA, Nikiforova MN, Caudill CM, Lloyd RV:
Solid variant of papillary thyroid carcinoma: incidence, clini-
cal-pathologic characteristics, molecular analysis, and bio-
logic behavior.  Am J Surg Pathol 2001, 25:1478-84.
Matched histological sample of papillary carcinoma solid vari- ant Figure 6
Matched histological sample of papillary carcinoma solid vari-
ant. At higher magnification note the nuclear features of the 
neoplastic cells leading to the morphological diagnosis of 
PTC in its solid variant. (H&E staining 25×)
Matched histological sample of papillary carcinoma solid vari- ant Figure 5
Matched histological sample of papillary carcinoma solid vari-
ant. Note the solid architecture of this carcinoma traversed 
by delicate fibrous septa that delimitates islands and sheets of 
neoplastic cells (H&E staining 10×)Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
CytoJournal 2008, 5:2 http://www.cytojournal.com/content/5/1/2
Page 5 of 5
(page number not for citation purposes)
3. Segev DL, Clark DP, Zeiger MA, Umbricht C: Beyond the suspi-
cious thyroid fine needle aspirate. A review.  Acta Cytol 2003,
47:709-22. Review
4. Xing M: BRAF Mutation in Papillary Thyroid Cancer: Patho-
genic Role, Molecular Bases, and Clinical Implications.  Endocr
Rev 2007, 28:742-62.
5. Xing M, Tufano RP, Tufaro AP, Basaria S, Ewertz M, Rosenbaum E,
Byrne PJ, Wang J, Sidransky D, Ladenson PW: Detection of BRAF
mutation on fine needle aspiration biopsy specimens: a new
diagnostic tool for papillary thyroid cancer.  J Clin Endocrinol
Metab 2004, 89:2867-72.
6. Salvatore G, Giannini R, Faviana P, Caleo A, Migliaccio I, Fagin JA, Niki-
forov YE, Troncone G, Palombini L, Basolo F, Santoro M: Analysis
of BRAF point mutation and RET/PTC rearrangement
refines the fine-needle aspiration diagnosis of papillary thy-
roid carcinoma.  J Clin Endocrinol Metab 2004, 89:5175-80.
7. Cohen Y, Rosenbaum E, Clark DP, Zeiger MA, Umbricht CB, Tufano
RP, Sidransky D, Westra WH: Mutational analysis of BRAF in
fine needle aspiration biopsies of the thyroid: a potential
application for the preoperative assessment of thyroid nod-
ules.  Clin Cancer Res 2004, 10:2761-5.
8. Sapio MR, Posca D, Raggioli A, Guerra A, Marotta V, Deandrea M,
Motta M, Limone PP, Troncone G, Caleo A, Rossi G, Fenzi G, Vitale
M: Detection of RET/PTC, TRK and BRAF mutations in pre-
operative diagnosis of thyroid nodules with indeterminate
cytological findings.  Clin Endocrinol (Oxf) 2007, 66:678-83.
9. Rowe LR, Bentz BG, Bentz JS: Utility of BRAF V600E mutation
detection in cytologically indeterminate thyroid nodules.
Cytojournal 2006, 3:10.
10. Jin L, Sebo TJ, Nakamura N, Qian X, Oliveira A, Majerus JA, Johnson
MR, Lloyd RV: BRAF mutation analysis in fine needle aspira-
tion (FNA) cytology of the thyroid.  Diagn Mol Pathol 2006,
15:136-43.
11. Trovisco V, Vieira de Castro I, Soares P, Máximo V, Silva P, Magalhães
J, Abrosimov A, Guiu XM, Sobrinho-Simões M: BRAF mutations
are associated with some histological types of papillary thy-
roid carcinoma.  J Pathol 2004, 202:247-51.
12. Trovisco V, Soares P, Soares R, Magalhães J, Sá-Couto P, Sobrinho-
Simões M: A new BRAF gene mutation detected in a case of a
solid variant of papillary thyroid carcinoma.  Hum Pathol 2005,
36:694-7.
13. Lupi C, Giannini R, Ugolini C, Proietti A, Berti P, Minuto M, Materazzi
G, Elisei R, Santoro M, Miccoli P, Basolo F: Association of BRAF
V600E mutation with poor clinicopathological outcomes in
500 consecutive cases of papillary thyroid carcinoma.  J Clin
Endocrinol Metab 2007, 92:4085-90.